1. Stockwell C. Nature’s Pharmacy. Century Hutchinson Ltd., London, United Kingdom, 1988.
2. Clark AM. Natural products as a resource for new drugs, Pharmaceut Res. 1996;13:1133-1141.
3. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564-582.
4. Razzaghi-Abyaneh M, Shams-Ghahfarokhi M, Rezaee MB, Sakuda S. Natural Aflatoxin Inhibitors from Medicinal Plants. In: Rai M, Varma A (eds.) Mycotoxins in Food, Feed and Bioweapons, Springer-Verlag Publication, 2010, pp. 329-354.
5. Razzaghi-Abyaneh M, Shams-Ghahfarokhi M (2011) Natural Inhibitors of Food-borne Fungi from Plants and Microorganisms. In: Rai M, Chikindas M (eds.) Natural Antimicrobials in Food Safety and Quality, CABI Publisher, UK, 2011, pp. 182-203.
6. Borris RP. Natural products research: perspectives from a major pharmaceutical company, J Ethnopharmacol. 1996;51:29-38.
7. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils - A Review. Food Chem Toxicol. 2008;46:446-475.
8. Sharafzadeh S, Alizadeh O. Some medicinal plants cultivated in Iran. J Appl Pharmaceut Sci. 2012;2:134-137.
9. Pasrsa A. Medicinal plants and drugs of plant origin in Iran IV. Plant Foods Hum Nut 1959-1960;5-7:65-136.
10. Razzaghi-Abyaneh M, Yoshinari T, Shams-Ghahfarokhi M, Rezaee MB, Nagasawa H, Sakuda S. Dillapiol and apiol as specific inhibitors of the biosynthesis of aflatoxin G1 in Aspergillus parasiticus. Biosci Biotechnol Biochem. 2007;71:2329-2332.
11. Noorhosseini Niyaki SA, Ashoori Latmahalleh D, Allahyari MS, Doozandeh Masooleh P. Socio-economic factors for adoption of medicinal plants cultivation in Eshkevarat region, north of Iran. J Med Plants Res. 2011;5:30-38.
)